Cellmid is a consumer health company listed on the Australian Stock Exchange (ASX: CDY). Cellmid’s mission is to contribute to the healthy longevity of humanity. We develop scientifically validated innovative consumer products to help people live longer, in good health and with confidence. While developing consumer solutions to the conditions commonly associated with aging our team of scientists apply rigorous research protocols.
Through its wholly owned subsidiary Advangen, Cellmid develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis®, Advangen® Jo-Ju® and Lexilis® brands, is sold in channels including QVC Japan, premium retailer Nieman Marcus and Bloomingdales in the USA, Douglas Perfumery in Europe and in Priceline and other pharmacies and beauty retailers in Australia. Cellmid is rapidly expanding in other territories with distribution agreements signed in China and Korea. The Company continues to grow its product portfolio through dedicated research and development, concurrently to rapidly scaling into its global distribution network. Cellmid also works with distribution and licensing partners in most of its current markets. For further information visit www.evolisproducts.com.au.